News
Praxis soars on rare childhood epilepsy trial data
Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.
News
Protego's $130m for amyloidosis drug, and other financings
Our latest crop of biotech financings has nine-figure rounds for Protego and Triana, with Excelsior Sciences and SciNeuro also raising new funds.
R&D
CDMOs: Their crucial role and how to select one, with Sigma ...
Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.
R&D
Why pharma’s future may run through your local blood centre
With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
